For decades, the standard of care for obstructive sleep apnea (OSA) has been governed by a rigid metric: the 90-day compliance threshold. Under current Medicare guidelines—and subsequently adopted by most private insurers—patients are required to use their Continuous Positive Airway Pressure (CPAP) machines for at least four hours a night on 70% of nights during a specific 30-day window within the first three months of treatment. Failure to meet these specific parameters often results in the cessation of insurance coverage, effectively forcing patients to forfeit their devices.
However, a landmark study presented at the ATS 2026 International Conference is now calling these long-held assumptions into question. By analyzing a massive dataset from Kaiser Permanente Southern California, researchers have discovered that the "all-or-nothing" approach to CPAP compliance may be causing more harm than good, potentially stripping thousands of patients of a life-saving therapy before they have the chance to adapt.
The Foundation of a Disputed Policy: A Chronology of Compliance
To understand the weight of these new findings, one must first look at the history of CPAP reimbursement. Since the early 2000s, payers have utilized usage data transmitted by "smart" CPAP devices to determine the clinical necessity of the equipment. The logic was ostensibly cost-containment: if a patient is not using the device, they are not deriving benefit, and therefore the insurer should not continue to pay for the rental or purchase of the machine.
For years, this 90-day window was treated as a definitive "make-or-break" period. Clinicians and sleep centers were conditioned to view early non-adherence as a failure of the patient or the treatment, often leading to a termination of therapy.
However, the recent study, led by Dr. Dennis Hwang and his team, shifts the timeline of success. By observing over 132,000 patients within a system that does not automatically terminate coverage based on early usage, researchers were able to track what actually happens to "non-compliant" patients after the three-month mark. What they found was a significant disconnect between initial usage patterns and long-term therapeutic success.
Supporting Data: The Reality of "Non-Compliance"
The data derived from the Kaiser Permanente cohort provides a sobering look at how current policies may be misaligned with patient behavior.
- The Scale of the "Failure": The study revealed that 51% of patients—more than half of the study population—failed to meet the Medicare-defined criteria for 90-day adherence. Under standard insurance models, these patients would have been flagged for potential coverage termination.
- The Persistence of Users: Despite failing the early threshold, more than one-third of those "non-compliant" patients were still using their CPAP devices consistently one year later. This suggests that the initial 90-day window is not a predictor of long-term failure, but rather a period of adjustment for many patients.
- The Efficacy of Partial Usage: Perhaps most striking was the finding regarding usage duration. Many patients who did not hit the "four-hour" threshold were still utilizing their devices for an average of two hours per night. Clinical literature has long supported the fact that even two hours of CPAP use can provide measurable relief from sleep apnea symptoms, including reduced daytime sleepiness and improved cognitive function.
By labeling these patients as "non-adherent," the current system ignores the fact that these individuals are still obtaining clinical benefit from their treatment.
Official Responses and Clinical Perspectives
Dr. Dennis Hwang, a sleep and pulmonary physician at Kaiser Permanente Southern California and the study’s lead author, has been vocal about the implications of these findings.
"Our findings suggest clinicians and policymakers should not rely solely on Medicare-defined adherence, given its reliance on early CPAP use and an arbitrary four-hour threshold, when making long-term treatment decisions," Dr. Hwang stated in a press release. He emphasizes that the "four-hour rule" is largely an administrative convenience rather than a medically rigorous standard for every patient.
The medical community has long acknowledged that CPAP therapy is notoriously difficult to initiate. It involves wearing a mask while sleeping, managing airflow pressure, and dealing with potential skin irritation or claustrophobia. For many, the first 90 days are a steep learning curve. Dr. Hwang’s research reinforces the clinical intuition that many physicians have held for years: that some patients simply take longer to adapt to the therapy.
"While clinicians know some patients take time to adapt, the scale of continued use we observed in those that did not initially meet Medicare adherence was striking," Hwang noted.
The Broader Implications: Redefining "Success"
The implications of this research are far-reaching, touching on policy, patient equity, and the definition of clinical success.
Policy Reform
The primary implication is the need for a total overhaul of reimbursement policies. If a policy intended to save costs actually removes effective, life-saving treatment from patients who are slowly but surely building the habit, the policy is essentially counterproductive. Policymakers are being urged to move away from arbitrary thresholds and toward evidence-based metrics that account for individual patient progress.
Clinical Management
For clinicians, the study provides a mandate to offer more support rather than immediate withdrawal. Instead of viewing the 90-day mark as a deadline, the findings suggest that sleep centers should view it as a milestone for intervention. If a patient is struggling at 60 days, the appropriate response should be more coaching, mask adjustments, or education—not the threat of losing their device.
Patient Equity
There is a significant socio-economic component to CPAP compliance. Patients with limited resources, those with high stress, or those with comorbidities may struggle more in the early stages of therapy. If these patients are disproportionately penalized, the current system risks widening the gap in health outcomes, essentially punishing the most vulnerable for the difficulty of adjusting to a complex medical device.
Moving Toward Evidence-Based Coverage
The researchers are not suggesting that adherence doesn’t matter; rather, they are arguing that the measurement of adherence is currently flawed. The next phase of research will focus on identifying the profiles of patients who are most likely to succeed in the long term, even if they start slowly.
By analyzing behavioral patterns, comorbid conditions, and initial response to therapy, researchers hope to develop predictive models that help clinicians identify who needs extra support, rather than simply identifying who should be cut off from coverage.
Furthermore, the goal is to shift toward outcome-based metrics. If a patient’s blood pressure improves, their daytime alertness increases, and their partner reports less snoring, is that not the ultimate goal of the therapy? If those clinical outcomes are met, the question of whether they used the machine for exactly four hours per night becomes secondary.
Conclusion: A Call for Flexibility
The "90-day rule" has long been a fixture of the sleep medicine landscape, acting as a gatekeeper for access to care. However, as the research from the ATS 2026 conference demonstrates, this gatekeeping may be preventing many patients from finding their way to better health.
When more than a third of patients who "fail" the early criteria go on to become long-term users, the system is clearly misidentifying who is truly non-adherent. The findings presented by Dr. Hwang and his colleagues provide a robust, data-driven argument for flexibility.
As the medical field continues to embrace personalized medicine, it is becoming increasingly clear that the "one-size-fits-all" approach to CPAP compliance is a relic of a less sophisticated era. By extending support, providing patience during the critical initial adjustment phase, and focusing on real-world clinical outcomes rather than arbitrary time-clocks, the healthcare system can ensure that more patients with obstructive sleep apnea receive the consistent, effective care they need to lead healthier, more productive lives.
The path forward is clear: the focus must shift from policing usage to fostering long-term, sustainable patient engagement. Only then can we truly claim to be providing the best possible care for those living with the challenges of obstructive sleep apnea.
